[Efficiency of revaccination against epidemic parotitis and immunological safety].
Seventy-eight children aged 6-7 years were subcutaneously revaccinated with L-3 live mumps vaccine. The vaccine is slightly reactogenic and completely safe. The level of antibodies increased on day 10 postvaccination in 80% of children with initially low antibody titers. Subcutaneous revaccination resulted in appearance of anti-parotitis antibodies in nasal secretions of 60% and in the saliva of 20% children, this indicating sufficiently high immunogenic activity of the vaccine.
Iuminova
N V
NV
Aleksander
S K
SK
Liashchenko
V A
VA
Sidorenko
E S
ES
D000914:Antibodies, Viral / Q000097:blood / Q000276:immunology; D002648:Child; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D009107:Mumps / Q000097:blood / Q000276:immunology* / Q000517:prevention & control*; D009108:Mumps Vaccine / Q000008:administration & dosage* / Q000276:immunology
D000914:Antibodies, Viral; D009108:Mumps Vaccine